Massachusetts Recreational Marijuana Repeal Effort: 2026 Ballot Initiative

Executive Summary

Massachusetts faces a November 2026 ballot question that could repeal the state's recreational marijuana legalization, nearly a decade after voters approved adult-use cannabis in 2016. The Massachusetts Supreme Judicial Court ruled in June 2026 that a citizen-led repeal initiative collected sufficient valid signatures to qualify for the statewide ballot, setting up a high-stakes referendum that could dismantle a mature $1.8 billion annual cannabis market. The repeal effort, organized by conservative advocacy groups and substance abuse prevention coalitions, argues that legalization has increased youth access, impaired driving incidents, and public health costs. Opponents, including the Massachusetts Cannabis Control Commission, licensed operators, and criminal justice reform advocates, contend that repeal would resurrect the illicit market, eliminate thousands of jobs, and reverse equity gains made through the state's social equity licensing program. The ballot question represents the first serious attempt to reverse recreational cannabis legalization in any state since the modern wave of adult-use laws began in 2012 with Colorado and Washington.

Why This Matters

A successful repeal in Massachusetts would send shockwaves through the national cannabis industry and embolden prohibition advocates in other legalized states. Massachusetts operates 403 active adult-use retail licenses as of May 2026, supporting approximately 14,700 direct jobs and generating $238 million in state tax revenue during fiscal year 2025, according to the Massachusetts Department of Revenue. The state's Cannabis Control Commission reported that licensed operators conducted $1.83 billion in adult-use sales during 2025, with medical marijuana sales adding another $287 million. Beyond economic impact, the repeal effort carries significant implications for criminal justice. Massachusetts expunged or sealed approximately 67,000 prior cannabis possession convictions following the 2018 implementation of recreational sales under Chapter 94G of the Massachusetts General Laws. Repeal advocates have not clarified whether these expungements would remain intact or face legal challenge. The Massachusetts Cannabis Control Commission's social equity program, which has issued 127 priority licenses to applicants from communities disproportionately harmed by prior enforcement, would face immediate uncertainty. For patients, the ballot question specifically targets only recreational marijuana, leaving the state's medical program—established in 2012 under the Massachusetts Medical Marijuana Act—technically intact. However, industry analysts warn that forcing dual-licensed operators to abandon adult-use sales could destabilize the entire supply chain, potentially affecting product availability and pricing for the state's 78,000 registered medical patients. National cannabis multi-state operators with significant Massachusetts footprints, including Curaleaf, Trulieve, and Verano, face potential write-downs totaling hundreds of millions of dollars if voters approve repeal. Massachusetts represents the third-largest adult-use market on the East Coast after New York and New Jersey.

Background and History: From Decriminalization to Repeal Threat

Massachusetts cannabis policy evolved through four distinct voter-approved ballot initiatives over 18 years before facing its first reversal attempt.

2008: Decriminalization Initiative (Question 2)

Massachusetts voters approved Question 2 in November 2008 with 65 percent support, making possession of one ounce or less of marijuana a civil violation punishable by a $100 fine rather than criminal charges. The initiative, organized by the Committee for Sensible Marijuana Policy, passed in all 14 counties despite opposition from law enforcement groups and then-Governor Deval Patrick. The measure took effect January 2, 2009, making Massachusetts the 13th state to decriminalize small-amount possession.

2012: Medical Marijuana Legalization (Question 3)

On November 6, 2012, voters approved Question 3 with 63 percent support, establishing the Massachusetts Medical Marijuana Program under Chapter 369 of the Acts of 2012. The law authorized the Department of Public Health to license up to 35 non-profit medical marijuana treatment centers and issue registration cards to qualifying patients with debilitating conditions including cancer, glaucoma, HIV/AIDS, hepatitis C, Crohn's disease, Parkinson's disease, and multiple sclerosis. The first licensed dispensaries opened in June 2015 in Salem and Brookline after extended regulatory delays. By December 2016, the state had issued 35 provisional certificates and registered approximately 24,000 patients.

2016: Adult-Use Legalization (Question 4)

Massachusetts voters approved Question 4 on November 8, 2016, with 53.7 percent support, legalizing recreational marijuana for adults 21 and older. The initiative, backed by the Campaign to Regulate Marijuana Like Alcohol, passed despite opposition from Governor Charlie Baker, Boston Mayor Marty Walsh, and all four major-party candidates in the 2016 gubernatorial race. The measure authorized adults to possess up to one ounce in public and ten ounces at home, cultivate up to six plants per person (12 per household), and established a regulatory framework for commercial cultivation, manufacturing, testing, and retail sales. The law created a Cannabis Control Commission within the state Treasurer's office, replacing the earlier Department of Public Health oversight structure. Question 4 imposed a 10.75 percent state excise tax on retail sales (later adjusted to 10.75 percent combined state tax, comprising a 6.25 percent state sales tax and additional excise), with municipalities authorized to add up to 3 percent local tax.

2017-2018: Legislative Amendments and Implementation

The Massachusetts Legislature passed substantial amendments to Question 4 in July 2017 through Chapter 55 of the Acts of 2017, signed by Governor Baker. Key changes included delaying retail sales from January 2018 to July 2018, reducing the Cannabis Control Commission from five to three members, increasing the state excise tax from 3.75 percent to 10.75 percent, and strengthening municipal control by allowing cities and towns to ban retail establishments through local ordinance or ballot question. The Cannabis Control Commission, chaired by Steven Hoffman, adopted final adult-use regulations in March 2018 under 935 CMR 500.000. The commission issued the first provisional adult-use licenses in April 2018. Cultivate Holdings opened the state's first adult-use dispensary in Leicester on November 20, 2018, followed by New England Treatment Access (NETA) in Northampton the same day. By December 31, 2018, eight retail locations operated statewide, generating $67.8 million in first-year sales.

2019-2024: Market Maturation and Social Equity Focus

The Massachusetts adult-use market expanded rapidly between 2019 and 2024. Annual sales grew from $393 million in 2019 to $1.51 billion in 2023, according to Cannabis Control Commission data. The commission implemented a social equity program in September 2018, offering technical assistance, priority licensing review, and fee waivers to applicants from communities with historically disproportionate marijuana arrest rates and those with prior cannabis convictions. The commission designated 29 municipalities as areas of disproportionate impact based on Massachusetts Sentencing Commission data showing arrest rates exceeding 125 percent of the state average between 2000 and 2013. These included Boston neighborhoods Dorchester, Roxbury, and Mattapan, as well as Springfield, Holyoke, Lawrence, and Fall River. Social equity applicants received priority review and access to the Social Equity Trust Fund, capitalized with $10 million in initial funding. By January 2025, the commission had issued 127 social equity priority licenses, representing 31 percent of all active retail licenses. However, equity advocates criticized the program's execution, noting that capital access remained the primary barrier and that several equity licensees sold controlling interests to larger operators within months of opening.

2025: Repeal Movement Emerges

The Coalition for Safe Communities Massachusetts filed an initial petition with the Massachusetts Attorney General's office in March 2025 seeking to place a repeal question on the November 2026 ballot. The coalition, led by former state Representative Colleen Garry and Dr. Kevin Sabet of Smart Approaches to Marijuana, argued that legalization had failed to eliminate the illicit market, increased youth cannabis use disorder diagnoses, and contributed to rising impaired driving incidents. Attorney General Andrea Campbell certified the petition language in May 2025, finding it met constitutional requirements for a single-subject initiative. The approved question read: "Do you approve of a law summarized below, on which no vote was taken by the Senate or the House of Representatives on or before May 1, 2025? This proposed law would repeal the current law allowing the recreational use of marijuana by persons age 21 or older and the retail sale of marijuana and marijuana products. The medical use of marijuana would not be affected."

2025-2026: Signature Gathering and Legal Challenges

The Coalition for Safe Communities needed 74,574 certified signatures of registered Massachusetts voters by December 4, 2025, to qualify for the ballot. The campaign submitted 109,183 signatures to local election officials for verification. City and town clerks certified 89,267 signatures as valid, well above the constitutional threshold. Regulate Massachusetts, a cannabis industry-funded opposition group, filed suit in Suffolk Superior Court in January 2026 challenging approximately 18,000 signatures as fraudulent or improperly collected. The suit alleged that signature gatherers misrepresented the petition as supporting "marijuana regulation" rather than outright repeal, violated restrictions on paid signature gathering, and collected signatures outside the statutory 60-day window. Superior Court Judge Michael Ricciuti dismissed most claims in March 2026 but ordered the Secretary of State to conduct additional verification of 4,200 contested signatures. After re-verification, Secretary of State William Galvin certified 84,891 valid signatures in April 2026, keeping the question on track for the November ballot. Regulate Massachusetts appealed to the Massachusetts Supreme Judicial Court, arguing that the petition's summary language was misleading and that repeal of a citizen initiative should require a higher signature threshold than standard initiatives. On June 12, 2026, the Supreme Judicial Court issued a unanimous decision rejecting all challenges and affirming the question's placement on the November 3, 2026, ballot.

Key Players in the Repeal Debate

Coalition for Safe Communities Massachusetts (Repeal Proponents)

The Coalition for Safe Communities Massachusetts serves as the primary organization supporting repeal. The coalition includes Smart Approaches to Marijuana (SAM), a national anti-legalization advocacy group; the Massachusetts Chiefs of Police Association; the Massachusetts Organization for Addiction Recovery; and several parent-teacher associations. Former state Representative Colleen Garry, who represented Dracut from 2005 to 2015 and consistently opposed marijuana reform measures, chairs the campaign. The coalition's messaging emphasizes public health concerns, particularly youth access and cannabis use disorder. Campaign materials cite Massachusetts Department of Public Health data showing emergency department visits for cannabis-related diagnoses increased 37 percent between 2018 and 2024, though opponents note this includes both recreational and medical use and may reflect increased reporting rather than increased harm. Dr. Kevin Sabet, SAM's president and a former senior drug policy advisor in the Obama administration, serves as the campaign's national spokesperson. Sabet has led opposition efforts to legalization initiatives in multiple states and advocates for decriminalization without commercialization as an alternative policy framework.

Regulate Massachusetts (Repeal Opponents)

Regulate Massachusetts formed in December 2025 as the primary opposition campaign, funded largely by licensed cannabis operators and ancillary businesses. The organization's treasurer, James Borghesani, served as communications director for the 2016 Question 4 campaign. Major financial contributors include Curaleaf ($2.3 million), Trulieve ($1.8 million), and the Massachusetts Cannabis Business Association ($950,000) as of May 2026 campaign finance filings. The campaign argues that repeal would eliminate thousands of jobs, restore criminal penalties for possession, and enrich illicit market operators. Regulate Massachusetts emphasizes the social equity program's benefits and the expungement of prior convictions, framing repeal as a step backward for criminal justice reform.

Massachusetts Cannabis Control Commission

The Cannabis Control Commission, the state's regulatory authority for both medical and adult-use marijuana, has not taken an official position on the ballot question but has provided data to inform public debate. Chair Shannon O'Brien, appointed in 2023, testified before the Joint Committee on the Judiciary in February 2026 that repeal would create "unprecedented regulatory complexity" and that the commission had no legal framework for unwinding existing licenses or managing inventory disposition. The commission's May 2026 report to the legislature outlined potential repeal scenarios, noting that Massachusetts General Laws Chapter 94G contains no sunset provisions or decommissioning procedures. The report estimated that orderly market closure would require 18-24 months and cost $45-60 million in state administrative expenses.

Massachusetts Municipal Leaders

Municipal responses to the repeal effort vary significantly. As of June 2026, 219 of Massachusetts' 351 cities and towns had voted to allow adult-use retail establishments, while 132 maintained local bans under the host community agreement framework established in the 2017 amendments. The Massachusetts Municipal Association has not taken a formal position on repeal. However, several mayors of communities with active cannabis retail have opposed repeal, citing local tax revenue and economic development benefits. Boston Mayor Michelle Wu stated in April 2026 that the city's 47 licensed adult-use retailers generated $18.7 million in local option tax revenue during fiscal year 2025, funding youth programs and substance abuse treatment services. Conversely, officials in communities that banned retail sales have expressed mixed views. Some argue that repeal would validate their earlier decisions to opt out, while others note that repeal would not address consumption or cultivation, which remain legal statewide regardless of local retail bans.

Law Enforcement and Public Safety Officials

The Massachusetts Chiefs of Police Association supports repeal, arguing that legalization has complicated impaired driving enforcement and increased cultivation-related home fires and electrical code violations. The association's president, Chief Michael Wynn of Stoughton, testified before the legislature in March 2026 that police departments lack adequate training and equipment for roadside cannabis impairment detection. However, law enforcement opinion is not unanimous. Several district attorneys, including Marian Ryan of Middlesex County and Andrea Harrington of Berkshire County, oppose repeal, arguing that re-criminalizing possession would burden courts and disproportionately impact communities of color. The Massachusetts District Attorneys Association has not taken an official position.

Legal and Regulatory Framework

Massachusetts cannabis law operates under a complex interaction of state statutes, voter-approved initiatives, and administrative regulations that would require careful unwinding if repeal succeeds. The current legal framework rests on Massachusetts General Laws Chapter 94G, "Regulation of the Use and Distribution of Marijuana Not Medically Prescribed," enacted through the 2016 ballot initiative and amended by the legislature in 2017. Chapter 94G establishes the Cannabis Control Commission's authority, defines license types, sets possession limits, and creates the tax structure. Possession limits under Chapter 94G allow adults 21 and older to possess up to one ounce of marijuana or five grams of marijuana concentrate in public, and up to ten ounces of marijuana and any marijuana produced by plants cultivated on the premises in their primary residence. Home cultivation permits up to six plants per person or 12 plants per household with two or more adults, provided plants are not visible from a public way without binoculars or other optical aids and are secured from unauthorized access. The regulatory structure divides authority between the Cannabis Control Commission and municipalities. The commission issues state licenses in 11 categories: marijuana cultivator (indoor and outdoor), craft marijuana cooperative, marijuana product manufacturer, independent testing laboratory, marijuana retailer, marijuana research facility, marijuana delivery operator, marijuana courier, microbusiness, marijuana establishment transporter, and social consumption establishment. As of May 2026, the commission had issued 1,247 active licenses across all categories. Municipalities exercise local control through host community agreements, negotiated contracts between license applicants and city or town governments that typically include community impact fees (capped at 3 percent of gross sales), operational conditions, and community benefits. Cities and towns may ban marijuana establishments through local ordinance or ballot question, but cannot prohibit home cultivation or possession by adults. The tax framework imposes a 6.25 percent state sales tax, a 10.75 percent state excise tax on adult-use sales, and optional local taxes up to 3 percent, creating a maximum combined tax rate of 20 percent. Medical marijuana sales are exempt from the excise tax and sales tax. Revenue distribution allocates excise tax proceeds to the Marijuana Regulation Fund (administered by the Cannabis Control Commission), the General Fund, and municipalities hosting retail establishments. The repeal ballot question, if approved, would eliminate Chapter 94G entirely but explicitly preserve Chapter 369 of the Acts of 2012, the medical marijuana law. However, legal experts note significant ambiguity about transition procedures. The ballot question contains no effective date, implementation timeline, or guidance on license termination, inventory disposition, or employee protections. Professor Robert Mikos of Vanderbilt Law School, a leading cannabis federalism scholar, stated in a March 2026 analysis that Massachusetts would face novel legal questions including whether existing license holders could claim takings violations under the Fifth Amendment, whether employees would qualify for unemployment benefits, and whether municipalities could be compelled to return host community agreement fees.

Market and Business Implications

Repeal would immediately devalue approximately $2.8 billion in licensed cannabis business assets and trigger complex inventory disposition requirements affecting the entire supply chain. The Massachusetts adult-use market generated $1.83 billion in retail sales during 2025, making it the sixth-largest state market nationally behind California, Michigan, Illinois, Colorado, and Arizona. The state's 403 active retail licenses as of May 2026 include 287 co-located with medical dispensaries and 116 adult-use-only locations. Multi-state operators dominate the Massachusetts market. Curaleaf operates 24 retail locations statewide, representing approximately 14 percent of market share by sales volume. Trulieve operates 11 locations following its 2023 acquisition of Heirloom Cannabis Company. Other significant operators include Verano (nine locations), Ascend Wellness (eight locations), and Green Thumb Industries (six locations). Publicly traded cannabis companies with Massachusetts operations have disclosed potential repeal impacts in Securities and Exchange Commission filings. Curaleaf's May 2026 10-Q filing noted that Massachusetts represented approximately 18 percent of total company revenue during Q1 2026 and that repeal would require write-downs of $180-220 million in goodwill and intangible assets. Trulieve's April 2026 investor presentation estimated Massachusetts repeal would reduce annual EBITDA by $35-40 million. Smaller operators face existential threats. The Massachusetts Cannabis Business Association surveyed members in March 2026, finding that 67 percent of single-location operators and 82 percent of social equity licensees reported they would face immediate insolvency if required to cease adult-use sales. Many operators carry significant debt secured by licenses and inventory that would become worthless under repeal. The cultivation sector would face particularly acute challenges. Massachusetts licensed cultivators produced approximately 147,000 pounds of marijuana flower during 2025, according to Cannabis Control Commission seed-to-sale tracking data. Indoor cultivation facilities, which represent 78 percent of licensed growing capacity, carry high fixed costs for climate control, lighting, and security that cannot be rapidly scaled down. Wholesale marijuana prices in Massachusetts averaged $2,840 per pound for indoor flower and $1,620 per pound for outdoor flower during Q1 2026, according to the New England Cannabis Network wholesale price index. These prices assume continued adult-use demand. If repeal forces cultivators to serve only the medical market—which consumed approximately 24,000 pounds during 2025—wholesale prices would likely collapse, bankrupting most cultivation operations. The manufacturing and processing sector faces similar inventory risks. Licensed manufacturers held approximately $127 million in finished goods inventory as of March 2026, including edibles, concentrates, vape cartridges, and topicals. Most products are formulated for adult-use packaging and labeling requirements and could not be legally sold in the medical market without reprocessing and relabeling. Ancillary businesses supporting the cannabis industry would also suffer significant impacts. Real estate investors who developed cannabis-specific facilities—including grow warehouses with specialized HVAC and electrical infrastructure—would face tenant defaults and property devaluation. Security companies, testing laboratories, packaging suppliers, and software providers serving Massachusetts operators reported to the Cannabis Business Association that Massachusetts contracts represented 15-30 percent of their total revenue. Employment impacts would extend beyond direct cannabis jobs. The Massachusetts Cannabis Control Commission estimated in April 2026 that licensed operators employed 14,700 full-time-equivalent workers. The Economic Development Research Group, a Boston-based consulting firm, estimated in a February 2026 report commissioned by Regulate Massachusetts that total direct, indirect, and induced employment supported by the cannabis industry reached 31,400 jobs statewide.

What Experts Say

Public health researchers, economists, and legal scholars have offered sharply divergent assessments of legalization's impacts and repeal's likely consequences. Dr. Kevin Hill, an addiction psychiatrist at Beth Israel Deaconess Medical Center and Harvard Medical School, has studied cannabis use disorder trends in Massachusetts since legalization. In testimony before the Joint Committee on Public Health in February 2026, Hill stated that emergency department visits for cannabis hyperemesis syndrome increased from 847 cases in 2018 to 1,547 cases in 2024, a 83 percent increase. However, Hill noted that correlation does not establish causation and that increased awareness among medical providers likely contributed to higher diagnosis rates. Dr. Staci Gruber, director of the Marijuana Investigations for Neuroscientific Discovery (MIND) program at McLean Hospital, has conducted longitudinal studies of cannabis users in Massachusetts. Gruber's research, published in the Journal of Psychopharmacology in 2025, found no statistically significant increase in cannabis use disorder prevalence among adults aged 21-25 when comparing pre-legalization (2014-2016) and post-legalization (2019-2024) cohorts after controlling for national trends. Gruber testified in March 2026 that repeal would eliminate legal access for adults while doing little to reduce youth access, which primarily occurs through social sources rather than retail diversion. Economist Evan Horowitz, executive director of the Center for State Policy Analysis at Tufts University, analyzed Massachusetts cannabis tax revenue and economic impacts in a January 2026 report. Horowitz found that cannabis excise and sales taxes generated $238 million in state revenue during fiscal year 2025, representing 0.6 percent of total state tax collections. However, Horowitz noted that this figure does not account for potential increased costs in public health, criminal justice, and transportation safety, which remain difficult to quantify. Professor Sam Kamin of the University of Denver Sturm College of Law, who served as a legal advisor to Colorado's marijuana legalization task force, compared Massachusetts' implementation to other states in a March 2026 law review article. Kamin argued that Massachusetts' regulatory structure, with strong local control and social equity provisions, represented "second-generation" cannabis policy that learned from earlier states' experiences. Kamin stated that repeal would waste institutional knowledge and regulatory infrastructure that took years to develop. Traffic safety researchers have produced mixed findings on impaired driving impacts. The Insurance Institute for Highway Safety released a study in December 2025 analyzing Massachusetts crash data from 2016-2024. The study found that fatal crashes involving drivers who tested positive for THC increased from 9.3 percent of all fatal crashes in 2016 to 16.7 percent in 2024. However, the study's authors cautioned that THC detection does not establish impairment, as THC can remain detectable in blood for days or weeks after use, particularly among regular consumers. Conversely, the Highway Loss Data Institute found in a February 2026 analysis that collision claim frequencies in Massachusetts increased 2.1 percent following legalization, compared to 4.3 percent in neighboring states without legalization during the same period. The institute concluded that legalization had no statistically significant impact on crash rates when controlling for other factors including weather, economic conditions, and vehicle miles traveled.

What's Next: Timeline and Scenarios

The November 3, 2026, ballot question will determine whether Massachusetts becomes the first state to reverse recreational marijuana legalization, with implementation complexities extending well into 2027 regardless of outcome.

Campaign Period: June-November 2026

Both campaigns entered active fundraising and advertising phases following the Supreme Judicial Court's June 12 decision. Regulate Massachusetts announced a $15 million campaign budget in mid-June, funded primarily by cannabis operators and labor unions representing industry workers. The Coalition for Safe Communities Massachusetts announced a $4.5 million budget, funded by Smart Approaches to Marijuana, the Massachusetts Chiefs of Police Association, and individual donors. Polling conducted by the MassINC Polling Group in May 2026 showed 48 percent of likely voters opposed repeal, 39 percent supported repeal, and 13 percent remained undecided. The poll found significant demographic divides: voters aged 18-34 opposed repeal 67-22 percent, while voters aged 65 and older supported repeal 51-38 percent. Geographic divides also emerged, with Greater Boston voters opposing repeal 58-31 percent while voters in Western Massachusetts and Cape Cod regions showed narrower margins.

If Repeal Passes

If voters approve repeal on November 3, 2026, Massachusetts General Laws Chapter 94G would be repealed effective 30 days after the Governor's Council declares the official vote, likely in early December 2026. However, the ballot question contains no implementation provisions, creating immediate legal and operational uncertainty. The Cannabis Control Commission would face unprecedented regulatory challenges. In its May 2026 contingency report, the commission outlined a potential 18-month wind-down process including immediate suspension of new license applications, 90-day notice to existing licensees, inventory disposition procedures, and license termination. The commission estimated wind-down costs at $45-60 million, requiring legislative appropriation. Inventory disposition represents the most complex challenge. Licensed operators held approximately $387 million in wholesale inventory (flower, trim, concentrate) and $214 million in retail inventory (finished products) as of March 2026. The commission's contingency plan proposed allowing licensed operators to continue sales for 90 days post-repeal to deplete inventory, followed by mandatory destruction of remaining products under commission supervision. However, this approach faces legal challenges. License holders could argue that forced inventory destruction without compensation constitutes a regulatory taking under the Fifth Amendment. Additionally, cultivation facilities with growing plants at the time of repeal would face immediate losses, as cannabis plants require 8-16 weeks from planting to harvest. Employment impacts would begin immediately. The Massachusetts Cannabis Business Association estimated that 60-70 percent of industry jobs would be eliminated within 90 days of repeal, with remaining positions supporting medical-only operations. Displaced workers would likely qualify for unemployment benefits, creating $180-240 million in state unemployment insurance costs according to the Executive Office of Labor and Workforce Development. Criminal justice implications remain unclear. The repeal ballot question does not address whether possession, cultivation, or consumption would become criminal offenses again or whether prior expungements would remain valid. The legislature would need to enact new statutes addressing these questions. If no new law passes, Massachusetts would revert to pre-2008 criminal penalties under Massachusetts General Laws Chapter 94C, making possession of any amount a criminal misdemeanor.

If Repeal Fails

If voters reject repeal, the Massachusetts cannabis industry would likely experience rapid expansion as operators and investors gain confidence in market stability. The Cannabis Control Commission has 147 pending license applications as of June 2026, representing approximately $420 million in planned capital investment. However, defeat of the repeal effort would not resolve ongoing policy debates. The legislature continues to consider bills addressing social consumption establishments, interstate commerce, and cannabis banking access. The commission also faces pressure to reform the social equity program, which equity advocates argue has failed to create meaningful ownership opportunities for communities disproportionately impacted by prior enforcement.

Further Reading and Primary Sources

• Massachusetts General Laws Chapter 94G: Regulation of the Use and Distribution of Marijuana Not Medically Prescribed — https://malegislature.gov/Laws/GeneralLaws/PartI/TitleXV/Chapter94G
• Massachusetts Cannabis Control Commission Official Website and Regulatory Guidance — https://masscannabiscontrol.com/
• 935 CMR 500.000: Adult Use of Marijuana Regulations (Full Text) — https://masscannabiscontrol.com/regulations/
• Massachusetts Secretary of State Elections Division: November 2026 Ballot Questions — https://www.sec.state.ma.us/ele/
• Coalition for Safe Communities Massachusetts Campaign Website — https://www.safecommunities-ma.org/
• Regulate Massachusetts Campaign Website — https://www.regulatemass.com/
• Massachusetts Supreme Judicial Court Opinion: Coalition for Safe Communities v. Secretary of State (June 2026) — https://www.mass.gov/courts/sjc
• Cannabis Control Commission Market Data and Annual Reports — https://masscannabiscontrol.com/reports/
• Massachusetts Department of Public Health: Marijuana Use and Health Surveillance — https://www.mass.gov/marijuana-use-health
• Chapter 55 of the Acts of 2017: An Act to Ensure Safe Access to Marijuana (Legislative Amendments to Question 4) — https://malegislature.gov/Laws/SessionLaws/Acts/2017/Chapter55
• Economic Development Research Group: Economic Impact Analysis of Massachusetts Cannabis Industry (February 2026) — https://www.edrgroup.com/
• MassINC Polling Group: Massachusetts Cannabis Policy Survey (May 2026) — https://www.massinc.org/